CTN Webinar: Pharmacotherapy Trials for Adolescent Substance Use Disorders: From Concept to Execution.

Presented by Kevin M. Gray, MD (Medical University of South Carolina, SC Node).

Produced by the NIDA Clinical Trials Network's Clinical Coordinating Center, August 10, 2016

While several pharmacotherapies have been developed for substance use disorders (SUD) in adults, relatively few have been studied in adolescents, and complex design and execution issues must be addressed to optimize the potential impact of current and future research in this important area. This one-hour presentation discussed method, design, and key strategies for the optimization of conduct/execution, overall treatment adherence, participant enrollment and retention, documentation, and management of adverse events for adolescent SUD pharmacotherapy trials. With adequate understanding of challenges and opportunities in the design and conduct of these trials, attendees were equipped to incorporate this information into their research practices.

Learning objectives:

  • Identify key issues in the conceptualization/design of pharmacotherapy trials for adolescent substance use disorders (SUD)
  • Understand methods to optimize the management/execution of pharmacotherapy trials for adolescent SUD
  • Consider strategies to standardize design methods across adolescent SUD pharmacotherapy trials

(Webinar, Video, PDF, English, 2016)

Keywords: Adolescents | Adverse events | Pharmacological therapy | Research design | Retention - Research | Training | Clinical Coordinating Center webinar

Document No: 1222.

Gray, Kevin M. search
Bookmark and Share

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 8/2016 --